ESA with or without iron vs no treatment
Thromboembolic events · patients at any age with solid cancer or haematological malignancy
ESA with or without iron showed no clear difference in thromboembolic events5 (Subnet based on 50 studies including 15,408… compared with no treatment (moderate certainty).
1 finding from 1 review
- Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer… 2022 · Cochrane Headline outcomes onlyRR 1.82 [0.98, 3.41]Studies not reportedModerate